glp 1 health Nature Made GLP-1 Companion Pack, 30 Unflavoured and versatile—stir into any food or drink The GLP-1 revolution: What UAB

Specific considerations for autoimmune disease patients: Delayed gastric emptying may affect absorption of oral medications, including some immunosuppressants Monitoring challenges in distinguishing disease activity from medication side effects Importance of maintaining stable immunosuppression regimens Patients should seek immediate medical attention for severe, persistent abdominal pain (potential pancreatitis or gallbladder disease), vision changes, severe vomiting/dehydration, neck mass/hoarseness, or allergic reactions

News-Medical. News-Medical , 8 Jan

BMO's Seigerman said he's not convinced that the upcoming trial "is going to change the narrative around CagriSema." Novo also expects to begin a phase three trial investigating a higher dose of CagriSema in the second half of 2026

PMC Cambronne, X